MedTrace Logo

The Effectiveness of the Wim Hof Method in People with Spinal Cord Injury

NCT05704322 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-12-18

No results posted yet for this study

Summary

People with a spinal cord injury (SCI) often experience secondary medical complications. One of the methods that may help to prevent or deal with secondary complications in people with SCI is the Wim Hof Method (WHM). The WHM is based on three elements: 1) breathing exercises, 2) gradual cold exposure (cold showers, or cold water immersion), and 3) mindset. The primary objective of this randomized controlled trial is to assess the effects of WHM, involving breathing exercises, mindset (and cold exposure), on health-related quality of life in people with SCI. The secondary objectives are to assess the effects of WHM, involving breathing exercises, mindset (and cold exposure) in people with SCI on: inflammation markers, metabolic health, pulmonary function, body composition, sleep quality, spasticity, stress, and on chronic pain.

Conditions

  • Spinal Cord Injuries

Interventions

OTHER

Wim Hof Methode

The intervention groups will follow a 7-weeks intervention, with one practice session per week at the rehabilitation center led by Wim Hof or one of his instructors. Besides these joint weekly sessions, the intervention groups have to practice daily at home with the Wim Hof Method app.

Sponsors & Collaborators

  • Dr. C.J. Vaillant Fonds

    collaborator UNKNOWN

  • W.M. de Hoop Stichting

    collaborator UNKNOWN

  • Ars Donandi / Yske Walther fonds

    collaborator UNKNOWN

  • Reade foundation

    collaborator UNKNOWN

  • Stichting Reade

    lead OTHER

Principal Investigators

  • Sonja de Groot, PhD · Stichting Reade

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-27
Primary Completion
2024-12-01
Completion
2024-12-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05704322 on ClinicalTrials.gov